NCT00738764View on ClinicalTrials.gov

A Trial of PDL192 in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Cancer
Interventions
BIOLOGICAL

PDL192

Humanized anti-TWEAK receptor monoclonal IgG1 antibody

Trial Locations (2)

80045

Site Reference ID/Investigator# 53364, Aurora

85258

Site Reference ID/Investigator# 53365, Scottsdale

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00738764 - A Trial of PDL192 in Subjects With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter